Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome

Human Reproduction

Volumn 25, Issue 10, 2010, Pages 2612-2621

  Zhang, Heping ^a   Legro, Richard S ^b   Zhang, Jeffrey ^c   Zhang, Leon ^c   Chen, Xiang ^a   Huang, Hao ^a   Casson, Peter R ^d   Schlaff, William D ^e   Diamond, Michael P ^f   Krawetz, Stephen A ^f   Coutifaris, Christos ^g   Brzyski, Robert G ^h   Christman, Gregory M ⁱ   Santoro, Nanette ^e   Eisenberg, Esther ^j  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c Guilford High School   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

ⁱ UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^j EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

decision trees; ovulation induction; PCOS; treatment effectiveness

Indexed keywords

CLOMIFENE CITRATE; INSULIN; METFORMIN; SEX HORMONE BINDING GLOBULIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION TREE; DRUG EFFICACY; FEMALE; HORMONAL THERAPY; HUMAN; INCIDENCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; OVULATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE; WAIST HIP RATIO;

EID: 77956942004     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq210     Document Type: Article

References (29)

1. Atiomo WU, Pearson S, Shaw S, Prentice A, Dubbins P. Ultrasound criteria in the diagnosis of polycystic ovary syndrome (PCOS). Ultrasound Med Biol 2000;26:977-980.
2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-2749.
3. Balen AH, Platteau P, Andersen AN, Devroey P, Sorensen P, Helmgaard L, Arce JC. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility. BJOG 2006;113:1195-1202.
4. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006;12:673-683.
5. Boomsma CM, Fauser BC, Macklon NS. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 2008;26:72-84.
6. Breiman L, Friedman J, Stone C, Olshen R. Classification and Regression Trees. New York: Chapman and Hall, 1984.
7. Cataldo NA, Barnhart HX, Legro RS, Myers ER, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C et al. Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycycstic ovary syndrome. J Clin Endocrinol Metab 2008;93:3124-3127.
8. Chávez R, Cruz ME, Domínguez R. Differences in the ovulation rate of the right or left ovary in unilaterally ovariectomized rats: effect of ipsi-and contralateral vagus nerves on the remaining ovary. J Endocrinol 1987; 113:397-401.
9. Chen X, Wang M, Zhang HP. The use of classification trees for bioinformatics. WIREs Data Min Knowl Discov 2010 (in press).
10. Dickey RP, Taylor SN, Curole DN, Rye PH, Lu PY, Pyrzak R. Relationship of clomiphene dose and patient weight to successful treatment. Hum Reprod 1997;12:449-453.
11. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352:1223-1236.
12. Fukuda M, Fukuda K, Andersen CY, Byskov AG. Right-sided ovulation favours pregnancy more than left-sided ovulation. Hum Reprod 2000; 15:1921-1926.
13. Homburg R, Armar NA, Eshel A. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. Br Med J 1988;297:1024-1026.
14. Hull MG. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1987; 1:235-245.
15. Hulley SB, Cummings Steven R, Browner WS, Grady DG, Newman TB. Designing Clinical Research: An Epidemiologic Approach, 3rd edn. Philadelphia: LippincottWilliams andWilkins, 2007.
16. Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1999;84:1617-1622.
17. Imani B, Eijkemans MJ, de Jong FH, Payne NN, Bouchard P, Giudice LC, Fauser BC. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 2000;85:676-682.
18. Järvelä I, Nuojua-Huttunen S, Martikainen H. Ovulation side and cycle fecundity: a retrospective analysis of frozen/thawed embryo transfer cycles. Hum Reprod 2000;15:1247-1249.
19. Kullback S, Leibler RA. On information and sufficiency. Ann Math Stat 1951;22:79-86.
20. Legro RS, Myers ER, Barnhart HX, Carson SA, Diamond MP, Carr BR, Schlaff WD, Coutifaris C, McGovern PG, Cataldo NA et al. The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril 2006;86:914-933.
21. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007;356:551-566.
22. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA et al. Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene. J Clin Endocrinol Metab 2008;93:792-800.
23. Myers ER, Silva SG, Hafley G, Kunselman AR, Nestler JE, Legro RS. Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial. Contemp Clin Trials 2005;26:271-280.
24. Palomba S, Falbo A, Orio F, Rolino A, Zullo F. Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome. Fertil Steril 2009; 91:2557-2567.
25. Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG 2006; 113:1148-1159. (Pubitemid 44401208)
26. Rausch ME, Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, McGovern PG, Cataldo NA et al., for the Reproductive Medicine Network. Predictors of pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009;94: 3458-3466.
27. Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 2004;19:1734-1740.
28. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine-report of subgroup analysis in clinical trials. N Engl J Med 2007;357:2189-2194.
29. Zhang H, Singer B. Recursive Partitioning in the Health Sciences. New York: Springer, 1999.